Astellas Pharma, Taisho Pharmaceutical Both Deny Acquisition of Zepharma by Taisho Pharmaceutical.
Tokyo, Japan, Feb 10, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) ) - Astellas Pharma Astellas Pharma Inc. (アステラス製薬株式会社, and Taisho Pharmaceutical Taisho Pharmaceutical Co., Ltd. (大正製薬株式会社, commented February 9 on a news report by the Asahi Shimbun The Asahi Shimbun (朝日新聞, Asahi Shinbun .
The February 9 morning edition of the newspaper reported that the two companies have been in the final stage of discussion on the acquisition of Zepharma, Astella Pharma's subsidiary, by Taisho Pharmaceutical.
However, the two companies have issued a comment that they are constantly exploring ways to improve their business values but have not engaged in any concrete discussions.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion